EVerZom's investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative therapies Pending successful in vivo proof-o ...

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to ...

Oppo nailed the hardware of the two Find X9 models. However, quite a few people are having issues with the price tag. Oppo Find X9 and X9 Pro... After launching the Find X9 and Find X9 Pro in China in ...

The X300 runs Android 16 out of the box, now augmented by the company's OriginOS - it's a new development this year that leaves the other software ...

These data were presented today during a late-breaking session at the American Heart Association (AHA) Scientific Sessions and published simultaneously in The New England Journal of Medicine (NEJM) in ...

Lo hizo en 2023 y lo volverá a hacer en 2026. Bad Bunny compite por el premio al álbum del año por “Debí tirar ...

M2T-CD33 (LTI-214) has received FDA orphan drug designation, offering incentives like tax credits and market exclusivity for AML treatment. The treatment targets CD33, a glycoprotein present in 90% of ...

This study offers a valuable advance for neuroscience by extending a visualization tool that enables intuitive assessment of how dendritic and synaptic currents shape the output of neurons. The ...

In October 2025, VW's Polo Vivo registered its best sales in a year, with help from rental buyers. Here are SA's top-selling ...

Fintel reports that on November 4, 2025, HC Wainwright & Co. upgraded their outlook for Terns Pharmaceuticals (NasdaqGS:TERN) ...

Fintel reports that on November 4, 2025, Barclays maintained coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...